[Arterial hypertension : novelties in 2018]

Area of Science:

• Cardiology
• Hypertension Management
• Pharmacotherapy

Background:

• The 2018 European guidelines for adult hypertension management introduced significant updates.
• Previous management strategies are being revised based on new evidence and therapeutic approaches.

Purpose of the Study:

• To summarize key changes in the 2018 European hypertension guidelines.
• To highlight new recommendations for blood pressure measurement, pharmacotherapy, and patient adherence.
• To discuss specific guidelines for orthostatic hypotension and emerging concerns regarding hydrochlorothiazide use.

Main Methods:

• Review of the 2018 European Society of Cardiology (ESC) and European Society of Hypertension (ESH) guidelines.
• Analysis of new therapeutic concepts and recommendations.
• Inclusion of recent research on specific drug-related risks.

Main Results:

• Increased emphasis on out-of-office blood pressure monitoring.
• Recommendation for dual combination therapy as first-line treatment for most hypertensive patients.
• Promotion of single-pill combinations for improved adherence.
• Inclusion of guidelines for orthostatic hypotension management.
• Discussion of skin cancer risk associated with long-term hydrochlorothiazide use.

Conclusions:

• The updated guidelines promote a more proactive and patient-centered approach to hypertension management.
• New strategies aim to improve blood pressure control, medication adherence, and patient safety.
• Healthcare providers should integrate these updated recommendations into clinical practice.